insights into a phase i/ia study of venetoclax, ixazomib and dexamethasone for r/r al amyloidosis
Published 3 months ago • 55 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
3:21
insights into the management of systemic al amyloidosis
-
2:43
impact of the addition of daratumumab to the frontline treatment of patients with al amyloidosis
-
0:48
an ongoing phase i/ii dose-finding study of zn-d5 for r/r al amyloidosis
-
2:25
current and emerging immune therapies in al amyloidosis: updates on hbi0101 & bispecifics
-
4:01
in vitro characterization of response to venetoclax in al amyloidosis
-
1:17
novel treatment approaches being explored in amyloidosis: immunotherapeutic agents & venetoclax
-
2:48
an overview of trials in progress in al amyloidosis: highlights from isa 2024
-
4:58
findings of a phase i study of anitocabtagene autoleucel for the treatment of r/r myeloma
-
21:42
future computers will be radically different (analog computing)
-
4:44
small intestinal bacterial overgrowth(sibo) steals your nutrients – dr.berg
-
4:22
the difference between the colon and intestines
-
2:09
considerations for the timing of transplantation in al amyloidosis
-
0:52
imroz trial updates: isa-vrd versus vrd in patients with ndmm ineligible for transplant
-
1:37
a phase i/ii trial of seclidemstat in combination with azacitidine for patients with mds and cmml
-
3:16
the potential of at-02 as a therapeutic strategy in attr & al amyloidosis
-
0:51
insights into a phase i/ii study assessing golidocitinib in ptcl
-
1:44
insights into the phase ii tidal study
-
0:57
the importance of integrating basic science sessions into ascat 2024
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
1:45
a phase ii study of elritercept for lower-risk mds